Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bratislava Statement: consensus recommendations for improving pancreatic cancer care.
Prades J, Arnold D, Brunner T, Cardone A, Carrato A, Coll-Ortega C, De Luze S, Garel P, Goossens ME, Grilli R, Harris M, Louagie M, Malats N, Minicozzi P, Partelli S, Pastorekova S, Petrulionis M, Price R, Sclafani F, Smolkova B, Borras JM. Prades J, et al. Among authors: sclafani f. ESMO Open. 2020 Nov;5(6):e001051. doi: 10.1136/esmoopen-2020-001051. ESMO Open. 2020. PMID: 33188052 Free PMC article. Review.
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer.
Partelli S, Sclafani F, Barbu ST, Beishon M, Bonomo P, Braz G, de Braud F, Brunner T, Cavestro GM, Crul M, Trill MD, Ferollà P, Herrmann K, Karamitopoulou E, Neuzillet C, Orsi F, Seppänen H, Torchio M, Valenti D, Zamboni G, Zins M, Costa A, Poortmans P. Partelli S, et al. Among authors: sclafani f. Cancer Treat Rev. 2021 Sep;99:102208. doi: 10.1016/j.ctrv.2021.102208. Epub 2021 Apr 20. Cancer Treat Rev. 2021. PMID: 34238640 Review.
ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective.
Koessler T, Alsina M, Arnold D, Ben-Aharon I, Collienne M, Lutz MP, Neuzillet C, Obermannova R, Peeters M, Sclafani F, Smyth E, Valle JW, Wagner AD, Wyrwicz L, Fontana E, Moehler M. Koessler T, et al. Among authors: sclafani f. ESMO Open. 2022 Apr;7(2):100392. doi: 10.1016/j.esmoop.2022.100392. Epub 2022 Feb 16. ESMO Open. 2022. PMID: 35180656 Free PMC article.
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer.
Takaori K, Bassi C, Biankin A, Brunner TB, Cataldo I, Campbell F, Cunningham D, Falconi M, Frampton AE, Furuse J, Giovannini M, Jackson R, Nakamura A, Nealon W, Neoptolemos JP, Real FX, Scarpa A, Sclafani F, Windsor JA, Yamaguchi K, Wolfgang C, Johnson CD; IAP/EPC study group on the clinical managements of pancreatic cancer. Takaori K, et al. Among authors: sclafani f. Pancreatology. 2016 Jan-Feb;16(1):14-27. doi: 10.1016/j.pan.2015.10.013. Epub 2015 Nov 12. Pancreatology. 2016. PMID: 26699808 Review.
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group.
Sclafani F, Fontana E, Wyrwicz L, Wagner AD, Valle JW, Smyth E, Peeters M, Obermannova R, Neuzillet C, Lutz MP, Koessler T, Ben-Aharon I, Arnold D, Alsina M, Moehler M. Sclafani F, et al. Clin Colorectal Cancer. 2022 Sep;21(3):188-197. doi: 10.1016/j.clcc.2022.04.001. Epub 2022 Apr 25. Clin Colorectal Cancer. 2022. PMID: 35637095 Review.
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group.
Koessler T, Alsina M, Arnold D, Ben-Aharon I, Lutz MP, Obermannova R, Peeters M, Sclafani F, Smyth E, Valle JW, Wagner AD, Wyrwicz L, Fontana E, Moehler M. Koessler T, et al. Among authors: sclafani f. Br J Cancer. 2021 Sep;125(7):911-919. doi: 10.1038/s41416-021-01474-y. Epub 2021 Aug 23. Br J Cancer. 2021. PMID: 34426663 Free PMC article. Review.
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.
Bogaerts J, Sydes MR, Keat N, McConnell A, Benson A, Ho A, Roth A, Fortpied C, Eng C, Peckitt C, Coens C, Pettaway C, Arnold D, Hall E, Marshall E, Sclafani F, Hatcher H, Earl H, Ray-Coquard I, Paul J, Blay JY, Whelan J, Panageas K, Wheatley K, Harrington K, Licitra L, Billingham L, Hensley M, McCabe M, Patel PM, Carvajal R, Wilson R, Glynne-Jones R, McWilliams R, Leyvraz S, Rao S, Nicholson S, Filiaci V, Negrouk A, Lacombe D, Dupont E, Pauporté I, Welch JJ, Law K, Trimble T, Seymour M. Bogaerts J, et al. Among authors: sclafani f. Eur J Cancer. 2015 Feb;51(3):271-81. doi: 10.1016/j.ejca.2014.10.027. Epub 2014 Dec 24. Eur J Cancer. 2015. PMID: 25542058 Free PMC article. Review.
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study.
Lau D, Kalaitzaki E, Church DN, Pandha H, Tomlinson I, Annels N, Gerlinger M, Sclafani F, Smith G, Begum R, Crux R, Gillbanks A, Wordsworth S, Chau I, Starling N, Cunningham D, Dhillon T. Lau D, et al. Among authors: sclafani f. ESMO Open. 2020 Feb;5(1):e000638. doi: 10.1136/esmoopen-2019-000638. ESMO Open. 2020. PMID: 32079623 Free PMC article. Clinical Trial.
113 results